These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35046888)

  • 21. Evaluation of neutrophil gelatinase-associated lipocalin in normoalbuminuric normotensive type 1 diabetic adolescents.
    Demir K; Abaci A; Küme T; Altincik A; Catli G; Böber E
    J Pediatr Endocrinol Metab; 2012; 25(5-6):517-23. PubMed ID: 22876548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NGAL and cystatin C: two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: one year follow up.
    Papadopoulou-Marketou N; Skevaki C; Kosteria I; Peppa M; Chrousos GP; Papassotiriou I; Kanaka-Gantenbein C
    Hormones (Athens); 2015; 14(2):232-40. PubMed ID: 25402375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of urinary non-albumin protein with the different urinary marker for glomerular and tubular damage in patients with type 2 diabetes.
    Siddiqui K; Joy SS; Nawaz SS; Alnaqeb D; Mujammami M; Al-Rubeaan K
    BMC Nephrol; 2020 Jul; 21(1):255. PubMed ID: 32631266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significant association of urinary alpha-1-microglobulin compared to urinary neutrophil gelatinase-associated lipocalin with renal insufficiency in patients with type 2 diabetes.
    Chen G; Shan X; Wang H
    Nephrology (Carlton); 2021 May; 26(5):400-407. PubMed ID: 33484208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infusion of autologous bone marrow derived mononuclear stem cells potentially reduces urinary markers in diabetic nephropathy.
    Gaipov A; Taubaldiyeva Z; Askarov M; Turebekov Z; Kozina L; Myngbay A; Ulyanova O; Tuganbekova S
    J Nephrol; 2019 Feb; 32(1):65-73. PubMed ID: 30406605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration.
    Fu WJ; Li BL; Wang SB; Chen ML; Deng RT; Ye CQ; Liu L; Fang AJ; Xiong SL; Wen S; Tang HH; Chen ZX; Huang ZH; Peng LF; Zheng L; Wang Q
    Diabetes Res Clin Pract; 2012 Jan; 95(1):105-9. PubMed ID: 22015481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum neutrophil gelatinase-associated lipocalin as a potential biomarker of diabetic kidney disease in patients with childhood-onset type 1 diabetes.
    Lee JH; Yang FJ; Tsai WY; Lee CT; Liu SY; Yang WS; Tung YC
    J Formos Med Assoc; 2022 Apr; 121(4):832-840. PubMed ID: 34253435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary RBP and NGAL Levels are Associated with Nephropathy in Patients with Type 2 Diabetes.
    Wu J; Shao X; Lu K; Zhou J; Ren M; Xie X; Liu J; Xu Y; Ding Y; Shen X; Zhu C
    Cell Physiol Biochem; 2017; 42(2):594-602. PubMed ID: 28954270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients.
    Chou KM; Lee CC; Chen CH; Sun CY
    PLoS One; 2013; 8(1):e54863. PubMed ID: 23349979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.
    Fu WJ; Xiong SL; Fang YG; Wen S; Chen ML; Deng RT; Zheng L; Wang SB; Pen LF; Wang Q
    Endocrine; 2012 Feb; 41(1):82-8. PubMed ID: 21779943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
    Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normal-range albuminuria does not exclude nephropathy in diabetic children.
    Zachwieja J; Soltysiak J; Fichna P; Lipkowska K; Stankiewicz W; Skowronska B; Kroll P; Lewandowska-Stachowiak M
    Pediatr Nephrol; 2010 Aug; 25(8):1445-51. PubMed ID: 20157738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Study of Role of Ngal in Diagnosis and Staging the Severity of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients in Sms Medical College, Jaipur.
    Joshi A; Mathur A; Parashar R; Jain R; Nehra A; Kesarwani S
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is Urinary NGAL Determination Useful for Monitoring Kidney Function and Assessment of Cardiovascular Disease? A 12-Month Observation of Patients with Type 2 Diabetes.
    Żyłka A; Gala-Błądzińska A; Dumnicka P; Ceranowicz P; Kuźniewski M; Gil K; Olszanecki R; Kuśnierz-Cabala B
    Dis Markers; 2016; 2016():8489543. PubMed ID: 28050059
    [No Abstract]   [Full Text] [Related]  

  • 35. Elevated Urinary VEGF-A, Transferrin, and Angiotensinogen Levels in Normoalbuminuric Children and Adolescents with Type 1 Diabetes: Can They Be Early Markers of Diabetic Kidney Disease?
    Dağdeviren Çakır A; Saygılı SK; Canpolat N; Konukoğlu D; Turan H; Çalışkan S; Sever L; Ercan O; Evliyaoğlu O
    Horm Res Paediatr; 2021; 94(11-12):426-432. PubMed ID: 34915504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma Neutrophil Gelatinase-Associated Lipocalin as a Marker of Tubular Damage in Diabetic Nephropathy.
    Kim SY; Jeong TD; Lee W; Chun S; Sunwoo S; Kim SB; Min WK
    Ann Lab Med; 2018 Nov; 38(6):524-529. PubMed ID: 30027695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes.
    Salem NA; El Helaly RM; Ali IM; Ebrahim HAA; Alayooti MM; El Domiaty HA; Aboelenin HM
    Pediatr Diabetes; 2020 Aug; 21(5):846-855. PubMed ID: 32304131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophil gelatinase-associated lipocalin and Cathepsin L as early predictors of kidney dysfunction in children with type 1 diabetes.
    Sołtysiak J; Skowrońska B; Fichna P; Stankiewicz W; Lewandowska-Stachowiak M; Ostalska-Nowicka D; Zachwieja J
    Endokrynol Pol; 2014; 65(6):479-84. PubMed ID: 25554617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence of Early Diabetic Nephropathy in Pediatric Type 1 Diabetes.
    Mamilly L; Mastrandrea LD; Mosquera Vasquez C; Klamer B; Kallash M; Aldughiem A
    Front Endocrinol (Lausanne); 2021; 12():669954. PubMed ID: 33995287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.